Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
16 July, 2018 08:07 IST
Lupin launches generic Safyral tablets in United States
Source: IRIS | 14 Mar, 2018, 09.39AM
Comments  |  Post Comment

Pharma major Lupin announced the launch of its Tydemy Tablets (Drospirenone, Ethinyl Estradiol, Levomefolate Calcium, 3mg/0.03mg/0.451mg and Levomefolate Calcium, 0.451mg) having received an approval from the United States Food and Drug Administration (FDA) earlier.

Lupin's Tydemy (Drospirenone, Ethinyl Estradiol, Levomefolate Calcium, 3mg/0.03mg/0.451mg & Levomefolate Calcium, 0.451mg) are the generic equivalents of Bayer HealthCare Pharmaceuticals Inc.'s Safyral tablets. It is indicated for use by women to prevent pregnancy and to raise folate levels in women who choose to use an oral contraceptive for contraception.

Drospirenone, EE, Levomefolate Calcium, 3mg/0.03mg/0.451mg & Levomefolate Calcium, 0.451mg tablets had annual sales of approximately USD 22 million in the US (IQVIA January 2018).

Shares of the company gained Rs 4.1, or 0.53%, to trade at  Rs 784.95.  The total volume of shares traded  was  5,849 at the BSE (9.29 a.m., Wednesday).



Lupin Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Infosys Q1 profit rises 4% y-o-y to Rs 36.12 bn - 13-Jul-2018 16:45
Fortis accepts Rs 40 bn investment offer from IHH Healthcare Berhad - 13-Jul-2018 10:38
White Organic Agro receives export order for 65 MT of cluster beans - 13-Jul-2018 09:51
Vakrangee partners with Reliance Nippon Life Asset Management - 13-Jul-2018 09:47
Larsen & Toubro wins orders worth Rs 30 bn - 13-Jul-2018 09:41
Cadila Healthcare's JV facility of Zydus Hopsira Oncology receives EIR from USFDA - 12-Jul-2018 13:23
Lupin receives nod for generic Nitrofurantoin capsules - 12-Jul-2018 12:39
Aban Offshore receives LoA for deployment of 3 jack-up rigs in UAE - 12-Jul-2018 12:26
Sun Pharma arm Dusa files lawsuit against Biofrontera - 12-Jul-2018 11:01
Larsen & Tubro wins orders worth Rs 23.88 bn - 12-Jul-2018 10:51
Alembic Pharma receives USFDA tentative approval for lloperidone Tablets - 12-Jul-2018 10:46
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer